Isomorphic Labs reportedly in early funding talks at a valuation of at least $40 billion

Bloomberg, citing people familiar with the effort, reports that Isomorphic Labs is in early talks to raise new funds at a valuation of at least $40 billion. The AI-powered drug discovery startup spun out of Alphabet’s Google DeepMind.